BVF Inc’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

BVF Inc’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,840	Closed	-$664K	–	59
2019 Q4	$664K	Buy	9,840 +4,771	+94%	+$552K	0.05%	55
2019 Q3	$947K	Sell	5,069 -738	-13%	-$169K	0.1%	56
2019 Q2	$1.55M	Sell	5,807 -1,428	-20%	-$479K	0.17%	53
2019 Q1	$2.73M	Buy	7,235 +3,153	+77%	+$1.06M	0.31%	47
2018 Q4	$1.52M	Sell	4,082 -148	-3%	-$58.1K	0.2%	48
2018 Q3	$1.83M	Hold	4,230	–	–	0.16%	53
2018 Q2	$1.53M	Sell	4,230 -244	-5%	-$115K	0.15%	49
2018 Q1	$2.04M	Hold	4,474	–	–	0.21%	40
2017 Q4	$2.58M	Buy	+4,474	New	+$2.95M	0.31%	39

Other funds holding FRTX

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BVF Inc's FRTX Position: Q1 2020 in Review

BVF Inc sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2020, closing a stake of 9,840 shares — an estimated $664K sold.

BVF Inc first reported a position in FRTX in Q4 2017 and held it in 9 quarters. The position peaked at $2.73M in Q1 2019. 14 funds tracked by Wall St. Rank hold FRTX as of Q1 2020.

BVF Inc reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
BVF Inc sold 9,840 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $664K.
BVF Inc first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
BVF Inc's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $2.73M in Q1 2019.
14 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2020.

Based on BVF Inc's 13F filing for Q1 2020, filed 15 May 2020.